Biotech company ORIG3N scores $3.1 mln

Boston-based biotech company ORIG3N has closed $3.1 million in funding. The investors included Hatteras Venture Partners, Harris & Harris Group, KTB and Mountain Group Capital.

ByIris Dorbian

6 February 2015•4 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

North America US Briefs

Biotech company ORIG3N scores $3.1 mln

Hatteras Venture Partners

Revvity Inc.